The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
- PMID: 39996161
- PMCID: PMC11848044
- DOI: 10.1002/ams2.70037
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Abstract
The 2024 revised edition of the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock (J-SSCG 2024) is published by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine. This is the fourth revision since the first edition was published in 2012. The purpose of the guidelines is to assist healthcare providers in making appropriate decisions in the treatment of sepsis and septic shock, leading to improved patient outcomes. We aimed to create guidelines that are easy to understand and use for physicians who recognize sepsis and provide initial management, specialized physicians who take over the treatment, and multidisciplinary healthcare providers, including nurses, physical therapists, clinical engineers, and pharmacists. The J-SSCG 2024 covers the following nine areas: diagnosis of sepsis and source control, antimicrobial therapy, initial resuscitation, blood purification, disseminated intravascular coagulation, adjunctive therapy, post-intensive care syndrome, patient and family care, and pediatrics. In these areas, we extracted 78 important clinical issues. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) method was adopted for making recommendations, and the modified Delphi method was used to determine recommendations by voting from all committee members. As a result, 42 GRADE-based recommendations, 7 good practice statements, and 22 information-to-background questions were created as responses to clinical questions. We also described 12 future research questions.
Keywords: evidence‐based medicine; infection; intensive care; organ failure; systematic review.
© 2025 The Author(s). Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine.
Conflict of interest statement
All committee members and working group members submitted disclosure forms of financial and academic conflict of interest (COI) prior to being requested to participate in individual activities. All COI were collected according to the guideline by the JSICM and the JAAM. Detailed information of COI and the roles in creating this clinical guideline are summarized in Data S4.
Figures









Similar articles
-
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024.J Intensive Care. 2025 Mar 14;13(1):15. doi: 10.1186/s40560-025-00776-0. J Intensive Care. 2025. PMID: 40087807 Free PMC article.
-
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).Acute Med Surg. 2021 Aug 26;8(1):e659. doi: 10.1002/ams2.659. eCollection 2021 Jan-Dec. Acute Med Surg. 2021. PMID: 34484801 Free PMC article.
-
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).J Intensive Care. 2021 Aug 25;9(1):53. doi: 10.1186/s40560-021-00555-7. J Intensive Care. 2021. PMID: 34433491 Free PMC article.
-
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af. Crit Care Med. 2013. PMID: 23353941
-
Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.Intensive Care Med. 2020 Feb;46(Suppl 1):10-67. doi: 10.1007/s00134-019-05878-6. Intensive Care Med. 2020. PMID: 32030529 Free PMC article.
Cited by
-
Disseminated intravascular coagulation.J Intensive Care. 2025 Jun 6;13(1):32. doi: 10.1186/s40560-025-00794-y. J Intensive Care. 2025. PMID: 40474215 Free PMC article. Review.
-
Recommendations for the use of biomarkers for the management of adults with sepsis: a scoping review and critical appraisal.BMJ Open. 2025 Jul 6;15(7):e090922. doi: 10.1136/bmjopen-2024-090922. BMJ Open. 2025. PMID: 40623745 Free PMC article.
References
-
- Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. - PubMed
-
- Bone RC, Balk RA, Cerra FB. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–1655. - PubMed
-
- Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med. 2003;29:530–538. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials